TELA Bio, Inc.

NasdaqGM:TELA 株式レポート

時価総額:US$115.9m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

TELA Bio 将来の成長

Future 基準チェック /26

TELA Bioは、54.8%と22.1%でそれぞれ年率54.8%で利益と収益が成長すると予測される一方、EPSはgrowで54%年率。

主要情報

54.8%

収益成長率

54.0%

EPS成長率

Medical Equipment 収益成長16.7%
収益成長率22.1%
将来の株主資本利益率n/a
アナリストカバレッジ

Low

最終更新日21 May 2024

今後の成長に関する最新情報

Earnings Update: TELA Bio, Inc. (NASDAQ:TELA) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Mar 24
Earnings Update: TELA Bio, Inc. (NASDAQ:TELA) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Recent updates

Shareholders May Be More Conservative With TELA Bio, Inc.'s (NASDAQ:TELA) CEO Compensation For Now

May 29
Shareholders May Be More Conservative With TELA Bio, Inc.'s (NASDAQ:TELA) CEO Compensation For Now

TELA Bio, Inc. (NASDAQ:TELA) Soars 31% But It's A Story Of Risk Vs Reward

May 23
TELA Bio, Inc. (NASDAQ:TELA) Soars 31% But It's A Story Of Risk Vs Reward

Earnings Update: TELA Bio, Inc. (NASDAQ:TELA) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Mar 24
Earnings Update: TELA Bio, Inc. (NASDAQ:TELA) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Many Still Looking Away From TELA Bio, Inc. (NASDAQ:TELA)

Mar 08
Many Still Looking Away From TELA Bio, Inc. (NASDAQ:TELA)

TELA Bio (NASDAQ:TELA) Has Debt But No Earnings; Should You Worry?

Oct 07
TELA Bio (NASDAQ:TELA) Has Debt But No Earnings; Should You Worry?

Getting In Cheap On TELA Bio, Inc. (NASDAQ:TELA) Might Be Difficult

Jul 31
Getting In Cheap On TELA Bio, Inc. (NASDAQ:TELA) Might Be Difficult

TELA Bio: Tailwinds In Hernia Repair Market And Promising Clinical Data To Drive Accelerating Adoption

Oct 02

Tela Bio prices $32M common stock offering

Aug 16

Is TELA Bio (NASDAQ:TELA) Using Debt Sensibly?

May 12
Is TELA Bio (NASDAQ:TELA) Using Debt Sensibly?

TELA Bio - Follow Up With Management

Jan 14

Our First Look At TELA Bio

Nov 04

TELA Bio Plugging Away

Oct 25

TELA Bio (TELA) Investor Presentation - Slideshow

May 26

Bearish: Analysts Just Cut Their TELA Bio, Inc. (NASDAQ:TELA) Revenue and EPS estimates

Mar 30
Bearish: Analysts Just Cut Their TELA Bio, Inc. (NASDAQ:TELA) Revenue and EPS estimates

Health Check: How Prudently Does TELA Bio (NASDAQ:TELA) Use Debt?

Feb 12
Health Check: How Prudently Does TELA Bio (NASDAQ:TELA) Use Debt?

TELA Bio guides Q4 and FY20 revenue below consensus

Jan 14

TELA Bio EPS misses by $0.09, beats on revenue

Nov 11

業績と収益の成長予測

NasdaqGM:TELA - アナリストの将来予測と過去の財務データ ( )USD Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
12/31/2026123-14N/AN/A3
12/31/202596-34N/AN/A5
12/31/202475-39N/AN/A5
3/31/202463-40-44-44N/A
12/31/202358-47-41-41N/A
9/30/202353-44-42-41N/A
6/30/202349-44-43-41N/A
3/31/202345-45-44-42N/A
12/31/202241-44-43-41N/A
9/30/202238-43-40-39N/A
6/30/202235-40-39-38N/A
3/31/202232-36-33-32N/A
12/31/202129-33-31-30N/A
9/30/202127-32-28-28N/A
6/30/202124-32-25-25N/A
3/31/202120-30-26-26N/A
12/31/202018-29-25-24N/A
9/30/202017-28-25-25N/A
6/30/202016-27-28-26N/A
3/31/202016-29-27-25N/A
12/31/201915-30-28-26N/A
9/30/201913-32-28-24N/A
6/30/201911-30-24-22N/A
3/31/201910-28-24-22N/A
12/31/20188-30-21-20N/A
12/31/20174-27N/A-16N/A

アナリストによる今後の成長予測

収入対貯蓄率: TELA今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: TELA今後 3 年間、利益が出ない状態が続くと予測されています。

高成長収益: TELA今後 3 年間、利益が出ない状態が続くと予測されています。

収益対市場: TELAの収益 ( 22.1% ) US市場 ( 8.7% ) よりも速いペースで成長すると予測されています。

高い収益成長: TELAの収益 ( 22.1% ) 20%よりも速いペースで成長すると予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: TELAの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です


成長企業の発掘